US2016324845A1PendingUtilityA1

Nicotine salt with meta-salicylic acid and applications therein

Assignee: ALEXZA PHARMACEUTICALS INCPriority: Jul 11, 2013Filed: Jul 19, 2016Published: Nov 10, 2016
Est. expiryJul 11, 2033(~7 yrs left)· nominal 20-yr term from priority
A61P 25/34A61M 2230/205A61M 2230/42A61M 2016/0015C07D 401/04A61M 15/002A61K 9/7007A61M 11/042A61M 15/0083A61M 2205/3584A61M 2205/8206A61M 5/00A61K 31/465A61M 11/001A61M 2205/364C07C 2601/16A61M 15/0081A61M 31/00A61K 31/60A61M 15/0066A61M 2205/3653A61K 9/0004A61M 2205/52A61M 2230/06A61M 11/041A61M 15/06A61K 9/007A61M 37/00A61M 2205/3576A61M 2205/276A61M 2205/3592A61M 2230/30A61M 35/00A61M 15/0065A61M 2205/368A61M 2209/06A61M 2205/3553A61M 2205/3368A24B 15/167A61M 2205/3569A61M 11/047C07C 63/08H05B 1/025A61M 2205/50C07C 65/10A24F 47/002C07C 2101/16A24F 40/46A24F 40/20
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present disclosure relates generally to the field of nicotine delivery. The disclosure teaches a nicotine meta-salicylate. More specifically, the disclosure teaches a condensation nicotine aerosol where nicotine meta-salicylate is vaporized. This disclosure relates to aerosol nicotine delivery devices. The delivery devices can be activated by actuation mechanisms to vaporize thin films comprising a nicotine meta-salicylate. More particularly, this disclosure relates to thin films of nicotine salt with meta salicylic acid for the treatment of nicotine craving and for effecting smoking cessation.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A drug delivery and drug cessation apparatus, comprising: a processor; and a non-transitory computer readable medium having stored thereon computer software comprising a set of instructions that, when executed by the processor, causes the apparatus to perform one or more functions, the set of instructions comprising: instructions to deliver, by a portable drug delivery device comprising a drug payload, a dosage delivery device, and a first wireless transceiver, a dose of a drug stored in the drug payload to a body of a user based on first instructions received from a portable control device comprising a second wireless transceiver, the portable control device being in wireless communication with the portable drug delivery device via the first wireless transceiver and the second wireless transceiver.

Join the waitlist — get patent alerts

Track US2016324845A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.